BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2854901)

  • 1. [Leishmaniasis caused by Leishmania viannia braziliensis (Lvb). A case of atypical course].
    Costa JM; Vale KC; França F; Lago EL; Magalhães AV; Marsden PD; Sampaio RN
    Rev Soc Bras Med Trop; 1988; 21(2):71-3. PubMed ID: 2854901
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
    Costa JM; Marsden PD
    Rev Soc Bras Med Trop; 1988; 21(2):85-6. PubMed ID: 3249826
    [No Abstract]   [Full Text] [Related]  

  • 3. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
    Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
    Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous leishmaniasis].
    Vion B
    Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
    Netto EM; Marsden PD; Llanos-Cuentas EA; Costa JM; Cuba CC; Barreto AC; Badaró R; Johnson WD; Jones TC
    Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of leishmaniasis in India.
    Thakur CP
    Indian J Pediatr; 1987; 54(1):7-10. PubMed ID: 3030933
    [No Abstract]   [Full Text] [Related]  

  • 8. Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
    Berhe N; Ali A; Hailu A; Yeneneh H
    Acta Trop; 1994 Jun; 57(1):83-90. PubMed ID: 7942358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis in clinical practice.
    Davidson RN
    J Infect; 1999 Sep; 39(2):112-6. PubMed ID: 10609527
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
    Motta AC; Arruda D; Souza CS; Foss NT
    Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the treatment of visceral leishmaniasis.
    Davidson RN; Croft SL
    Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
    [No Abstract]   [Full Text] [Related]  

  • 12. The chemotherapy of protozoal infections: whither?
    Steck EA
    J Protozool; 1981 Feb; 28(1):30-5. PubMed ID: 6265632
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple leg ulcers in a traveler.
    Cardenas GA; Gonzalez-Serva A; Cohen C
    Cleve Clin J Med; 2004 Feb; 71(2):109-12. PubMed ID: 14982193
    [No Abstract]   [Full Text] [Related]  

  • 14. Leishmaniasis.
    Evans TG
    Infect Dis Clin North Am; 1993 Sep; 7(3):527-46. PubMed ID: 8254158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leishmaniasis in French Guiana: a review.
    Dedet JP
    Am J Trop Med Hyg; 1990 Jul; 43(1):25-8. PubMed ID: 2200289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention of antimony in hair during leishmaniasis treatment.
    Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
    Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergency initiative to reduce leishmaniasis in Afghanistan.
    Querido J
    Lancet Infect Dis; 2004 Oct; 4(10):599. PubMed ID: 15470762
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous leishmaniasis: an overview.
    Hepburn NC
    J Postgrad Med; 2003; 49(1):50-4. PubMed ID: 12865571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse cutaneous leishmaniasis acquired in Peru.
    Franke ED; Lucas CM; Tovar AA; Kruger JH; De Rivera MV; Wignall FS
    Am J Trop Med Hyg; 1990 Sep; 43(3):260-2. PubMed ID: 2221221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon gamma therapy for cutaneous leishmaniasis.
    Kürkçüoğlu N; Tandoğdu R
    Arch Dermatol; 1990 Jun; 126(6):831-2. PubMed ID: 2111977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.